Memberships

MetrioPharm

MetrioPharm Memberships

MetrioPharm AG announces that it has enrolled the last patient with moderate-to-severe plaque psoriasis in its ongoing Phase II clinical trial.

Topics: Retrospect of the year by CEO Dr. Wolfgang Brysch, Events, Blog, Company Calendar

Subscribe to our press releases with the
MetrioPharm PR newsletter

Investors can subscribe to our quaterly corporate information with the
MetrioPharm IR newsletter

MetrioPharm AG

Bleicherweg 45
8002 Zurich

MetrioPharm Deutschland GmbH

Am Borsigturm 100
13507 Berlin